Expert Opinion on Emerging Drugs

853 papers and 15.0k indexed citations i.

About

The 853 papers published in Expert Opinion on Emerging Drugs in the last decades have received a total of 15.0k indexed citations. Papers published in Expert Opinion on Emerging Drugs usually cover Molecular Biology (186 papers), Oncology (170 papers) and Pulmonary and Respiratory Medicine (137 papers) specifically the topics of Lung Cancer Treatments and Mutations (29 papers), Chronic Lymphocytic Leukemia Research (27 papers) and Asthma and respiratory diseases (26 papers). The most active scholars publishing in Expert Opinion on Emerging Drugs are Jens J. Holst, Erik De Clercq, David R. Janero, Ruth A. Duffy, Len Neckers, David J. Hunter, Walter J. Lukiw, Gordon S. Lynch, Kang Choon Lee and Alexandros Makriyannis.

In The Last Decade

Fields of papers published in Expert Opinion on Emerging Drugs

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers published in Expert Opinion on Emerging Drugs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers published in Expert Opinion on Emerging Drugs.

Countries where authors publish in Expert Opinion on Emerging Drugs

Since Specialization
Citations

This map shows the geographic impact of research published in Expert Opinion on Emerging Drugs. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers published in Expert Opinion on Emerging Drugs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Expert Opinion on Emerging Drugs more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore journals with similar magnitude of impact

Rankless by CCL
2025